Home/Filings/4/0001012975-17-000726
4//SEC Filing

Birner Hubert 4

Accession 0001012975-17-000726

CIK 0001069308other

Filed

Sep 26, 8:00 PM ET

Accepted

Sep 27, 6:34 PM ET

Size

22.6 KB

Accession

0001012975-17-000726

Insider Transaction Report

Form 4
Period: 2017-09-19
Transactions
  • Other

    Common Stock

    2017-09-19+227,485227,485 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+663,782663,782 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+1,172,7091,172,709 total(indirect: See Footnote)
Transactions
  • Other

    Common Stock

    2017-09-19+663,782663,782 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+227,485227,485 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+1,172,7091,172,709 total(indirect: See Footnote)
Birner Hubert
Director10% Owner
Transactions
  • Other

    Common Stock

    2017-09-19+227,485227,485 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+663,782663,782 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+1,172,7091,172,709 total(indirect: See Footnote)
Transactions
  • Other

    Common Stock

    2017-09-19+663,782663,782 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+227,485227,485 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+1,172,7091,172,709 total(indirect: See Footnote)
Wanless Mark
10% Owner
Transactions
  • Other

    Common Stock

    2017-09-19+663,782663,782 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+1,172,7091,172,709 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+227,485227,485 total(indirect: See Footnote)
Leatt Gary
10% Owner
Transactions
  • Other

    Common Stock

    2017-09-19+227,485227,485 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+663,782663,782 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+1,172,7091,172,709 total(indirect: See Footnote)
Transactions
  • Other

    Common Stock

    2017-09-19+1,172,7091,172,709 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+663,782663,782 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+227,485227,485 total(indirect: See Footnote)
Marengere Luc
10% Owner
Transactions
  • Other

    Common Stock

    2017-09-19+227,485227,485 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+663,782663,782 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+1,172,7091,172,709 total(indirect: See Footnote)
Transactions
  • Other

    Common Stock

    2017-09-19+1,172,7091,172,709 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+663,782663,782 total(indirect: See Footnote)
  • Other

    Common Stock

    2017-09-19+227,485227,485 total(indirect: See Footnote)
Footnotes (4)
  • [F1]These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the "Merger Agreement"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. ("Acer"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing.
  • [F2]The shares are directly held by TVM Life Science Ventures VI GmbH & Co. KG ("TVM VI"). Hubert Birner ("Birner"), Stefan Fischer ("Fischer"), and Helmut Schuhsler ("Schuhsler") are members of the investment committee of TVM Life Science Ventures Management VI L.P. ("TVM VI Management"), a special limited partner of TVM VI, with voting and dispositive power over the shares held by TVM VI. TVM VI Management, Birner, Schuhsler and Fischer each disclaim beneficial ownership of the shares held by TVM VI, except to the extent of any pecuniary interest therein, if any. Birner is a director of the Issuer.
  • [F3]The shares are directly held by TVM Life Science Ventures VI L.P. ("TVM VI LP"). Birner, Schuhsler and Fischer are members of the investment committee of TVM VI Management, a special limited partner of TVM VI LP, with voting and dispositive power over the shares held by TVM VI LP. TVM VI Management, Birner, Schuhsler and Fischer each disclaim beneficial ownership of the shares held by TVM VI LP, except to the extent of any pecuniary interest therein, if any.
  • [F4]These shares are directly held by TVM Life Science Ventures VII L.P. ("TVM VII LP"). TVM Life Science Ventures VII (GP) Ltd. ("TVM VII GP Ltd") is the general partner of TVM VII LP. Luc Marengere ("Marengere"), Mark Wanless ("Wanless"), Gary Leatt ("Leatt"), Birner, Fischer and Schuhsler are members of the investment committee of TVM VII GP Ltd, which has voting and investment power with respect to these shares. TVM VII GP Ltd, Birner, Fischer, Schuhsler, Marengere, Wanless and Leatt each disclaim any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein, if any. Marengere is a director of the Issuer.

Issuer

Acer Therapeutics Inc.

CIK 0001069308

Entity typeother

Related Parties

1
  • filerCIK 0001398598

Filing Metadata

Form type
4
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 6:34 PM ET
Size
22.6 KB